GCM
WGS icon

Graham Capital Management’s GeneDx Holdings WGS Stock Holding History

Graham Capital Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,485
Closed -$268K – 1615
2025
Q3 		$268K Buy
+2,485
New +$271K ﹤0.01% 913
2025
Q1 		– Sell
-17,453
Closed -$1.34M – 1548
2024
Q4 		$1.34M Buy
17,453
+4,869
+39% +$340K 0.02% 414
2024
Q3 		$534K Buy
12,584
+3,371
+37% +$114K 0.01% 626
2024
Q2 		$241K Buy
+9,213
New +$175K 0.01% 801
2022
Q4 		– Sell
-10,938
Closed -$316K – 1378
2022
Q3 		$316K Buy
10,938
+9,920
+974% +$454K 0.01% 889
2022
Q2 		$42K Sell
1,018
-1,088
-52% -$73.8K ﹤0.01% 970
2022
Q1 		$213K Buy
+2,106
New +$234K 0.01% 818

Other funds holding WGS

CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Graham Capital Management's WGS Position: Q4 2025 in Review

Graham Capital Management sold out of GeneDx Holdings (WGS) in Q4 2025, closing a stake of 2,485 shares — an estimated $268K sold.

Graham Capital Management first reported a position in WGS in Q1 2022 and held it in 7 quarters. The position peaked at $1.34M in Q4 2024. 286 funds tracked by Wall St. Rank hold WGS as of Q4 2025.

  • Graham Capital Management reported no remaining GeneDx Holdings position as of Q4 2025 after selling out during the quarter.
  • Graham Capital Management sold 2,485 GeneDx Holdings shares in Q4 2025, an estimated $268K.
  • Graham Capital Management first reported a position in GeneDx Holdings in Q1 2022 and held it in 7 quarters.
  • Graham Capital Management's GeneDx Holdings position peaked at $1.34M in Q4 2024.
  • 286 funds tracked by Wall St. Rank held GeneDx Holdings as of Q4 2025.

Based on Graham Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.